Five Alarm Bios

The company develops small molecule therapeutics designed to target unexplored mechanisms of aging to delay or prevent age-related diseases. Their research leverages inherently safe biology to create treatments for a range of disabilities, specifically aiming to improve health outcomes for older populations. The firm conducts its primary research at the Babraham Campus near Cambridge.